Cuban officials announced on Monday that its homegrown, three-shot Abdala vaccine has proven to be 92.28% effective in its final stage of clinical trials. The announcement follows similar news over the weekend, when another Cuban-developed vaccine candidate, Soberana 2, was announced to be 62% effective with just two of its …
Read More »